Company Filing History:
Years Active: 2010-2022
Title: Satoru Noji: Innovator in Pharmaceutical Chemistry
Introduction
Satoru Noji is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 5 patents to his name, Noji's work has the potential to impact various therapeutic areas.
Latest Patents
One of Satoru Noji's latest patents is focused on crystalline forms of a Janus kinase inhibitor. This invention relates to the compound 3-((3S,4R)-3-methyl-6-(7H-pyrrolo [2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile, also known as Compound A. The patent details the compositions, methods of preparation, and methods of use for this compound. Another notable patent involves nitrogen-containing spirocyclic compounds, which are used in treating organ transplant rejection, graft versus host reaction after transplantation, autoimmune diseases, allergic diseases, and chronic myeloproliferative diseases.
Career Highlights
Satoru Noji is currently employed at Japan Tobacco Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has garnered attention in the scientific community, and he is recognized for his contributions to drug development.
Collaborations
Noji collaborates with talented colleagues, including Ryo Mizojiri and Kenta Aoki. Their combined expertise enhances the research and development efforts at Japan Tobacco Inc.
Conclusion
Satoru Noji is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new therapeutic options. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.